Apigenin inhibits the expression of high‐risk genes and acts as an anticancer agent to induce apoptosis in hepatocellular carcinoma cells by inhibiting the P13K/Akt/mTOR pathway.31, 32. Here, AKT1 is linked to hepatocellular carcinoma.